ELDN - CIK 0001404281
The table below shows Eledon Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $22.81M | $20.55M | $4.61M | $56.41M | $84.83M | $114.19M |
| Short-term investments | $110.53M | $119.63M | $46.49M | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $135.69M |
| $143.73M |
| $56.13M |
| $59.52M |
| $88.35M |
| $115.63M |
| Property, plant & equipment | - | - | - | - | - | $5.00K |
| Goodwill | - | - | $0.00 | $0.00 | $48.65M | $48.65M |
| Total assets | $169.01M | $177.41M | $89.07M | $92.79M | $170.55M | $197.19M |
| Accounts payable | $3.63M | $5.83M | $967.00K | $2.20M | $1.81M | $1.37M |
| Total current liabilities | $18.34M | $11.58M | $3.90M | $6.47M | $4.40M | $2.48M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $32.23M | $59.27M | $5.65M | $8.61M | $6.55M | $6.59M |
| Retained earnings | -$401.20M | -$355.59M | -$243.19M | -$202.87M | -$114.90M | -$80.39M |
| Total equity | $81.08M | $62.45M | $83.42M | $84.18M | $164.00M | $190.60M |